X-COR Therapeutics is a medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $2.6M
Founded date: 2017
Investors 1
| Date | Name | Website |
| 10.03.2022 | Good Growt... | goodgrowth... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.11.2020 | - | $2.6M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 17.11.2020 | Daily funding roundup - November 16th, 2020 | Undock raised $1.6M; Arrikto landed $10M; Gretel secured $12M; Chooch.ai picks up $20M Undock: Undoc... | vator.tv/n... |
| 12.11.2020 | X-COR Therapeutics Closes $2.6M Funding | FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alira Health (www.alirahealth.com), a leading international heal... | citybizlis... |
| 12.11.2020 | X-Cor Therapeutics Closes $2.6M Funding Round | X-COR Therapeutics, an Allston, MA-based developer of a novel extracorporeal carbon dioxide removal ... | finsmes.co... |